000 | 01910 a2200565 4500 | ||
---|---|---|---|
005 | 20250515140152.0 | ||
264 | 0 | _c20090107 | |
008 | 200901s 0 0 eng d | ||
022 | _a1535-3893 | ||
024 | 7 |
_a10.1021/pr800139r _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHarsha, H C | |
245 | 0 | 0 |
_aActivated epidermal growth factor receptor as a novel target in pancreatic cancer therapy. _h[electronic resource] |
260 |
_bJournal of proteome research _cNov 2008 |
||
300 |
_a4651-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aBiomarkers, Tumor |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aEnzyme Activation _xdrug effects |
650 | 0 | 4 |
_aErbB Receptors _xantagonists & inhibitors |
650 | 0 | 4 | _aErlotinib Hydrochloride |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGene Expression Profiling |
650 | 0 | 4 | _aGene Expression Regulation, Enzymologic |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunohistochemistry |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Nude |
650 | 0 | 4 |
_aPancreatic Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
650 | 0 | 4 |
_aProtein-Tyrosine Kinases _xgenetics |
650 | 0 | 4 |
_aProteomics _xmethods |
650 | 0 | 4 |
_aQuinazolines _xpharmacology |
650 | 0 | 4 | _aSubstrate Specificity |
650 | 0 | 4 |
_aTumor Burden _xdrug effects |
650 | 0 | 4 | _aXenograft Model Antitumor Assays |
700 | 1 | _aJimeno, Antonio | |
700 | 1 | _aMolina, Henrik | |
700 | 1 | _aMihalas, Anca B | |
700 | 1 | _aGoggins, Michael G | |
700 | 1 | _aHruban, Ralph H | |
700 | 1 | _aSchulick, Richard D | |
700 | 1 | _aKamath, Ullas | |
700 | 1 | _aMaitra, Anirban | |
700 | 1 | _aHidalgo, Manuel | |
700 | 1 | _aPandey, Akhilesh | |
773 | 0 |
_tJournal of proteome research _gvol. 7 _gno. 11 _gp. 4651-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1021/pr800139r _zAvailable from publisher's website |
999 |
_c18288632 _d18288632 |